Condition: Normal Pressure Hydrocephalus · Hydrocephalus · Sponsor: Johan Virhammar
To investigate if progression from prodromal into symptomatic NPH can be predicted from advanced neuroimaging, biomarkers in cerebrospinal fluid (CSF) and plasma and investigate the unknown mechanisms causing deterioration by investigating longitudinal changes in the above-mentioned variables. Three different cohorts with both asymptomatic and symptomatic patients as well as healthy controls will be investigated over time, both without intervention and before and after shunt surgery.
This description comes directly from the study's public registry record.
Johan Virhammar, MD, PhD · +46186110000 · johan.virhammar@neuro.uu.se
Always discuss trial participation with your own doctor first.
| Kuopio University Hospital | Kuopio, Finland | Not Yet Recruiting |
| Bellaria Hospital | Bologna, Italy | Recruiting |
| Sahlgrenska University Hospital | Gothenburg, Sweden | Not Yet Recruiting |
| Linköping University Hospital | Linköping, Sweden | Not Yet Recruiting |
| Karolinska University Hospital | Stockholm, Sweden | Not Yet Recruiting |
| Umeå University Hospital | Umeå, Sweden | Not Yet Recruiting |
| Uppsala University Hospital | Uppsala, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05910944